TriSalus Life Sciences In...
(TLSI)
undefined
undefined%
At close: undefined
5.04
0.00%
After-hours Jan 06, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Net Income | -59.04M | -47.19M | -28.84M | -711.39K |
| Depreciation & Amortization | 702.00K | 398.00K | 464.00K | 321.00K |
| Stock-Based Compensation | 1.40M | 368.00K | 109.00K | 22.00K |
| Other Working Capital | 953.00K | -2.57M | -1.84M | -569.98K |
| Other Non-Cash Items | 6.15M | 11.50M | 6.54M | 603.77K |
| Deferred Income Tax | n/a | 310.00K | -832.00K | n/a |
| Change in Working Capital | 740.00K | 2.30M | -131.00K | -569.98K |
| Operating Cash Flow | -50.05M | -32.31M | -22.70M | -677.60K |
| Capital Expenditures | -1.12M | -786.00K | -1.26M | -545.00K |
| Acquisitions | n/a | -1.00M | -1.00M | n/a |
| Purchase of Investments | n/a | n/a | n/a | -250.00M |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -1.53M | -1.00M | -1.00M | -9.16M |
| Investing Cash Flow | -2.12M | -1.79M | -2.26M | -250.00M |
| Debt Repayment | -87.00K | -131.00K | -1.30M | -178.08K |
| Common Stock Repurchased | -20.00K | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 54.72M | 13.59M | 52.07M | n/a |
| Financial Cash Flow | 54.63M | 13.46M | 50.77M | 252.01M |
| Net Cash Flow | 2.46M | -20.64M | 25.81M | -3.63M |
| Free Cash Flow | -51.17M | -33.10M | -23.95M | -1.22M |